News
-
-
Pharmacies smash 2018 flu
Monday | Dec 10 2018HEALTH Minister Greg Hunt has hailed the contribution of community pharmacies across Australia to reducing the incidence of flu last winter, with this year's successful primary care vaccination program helping deliver the lowest rates of influenza in the country since 2013.
-
Carmen get it!
Monday | Dec 10 2018THE team from Carmen Drive Pharmacy in the Sydney suburb of Carlingford (pictured) recently met with NSW Pharmacy Guild Senior Membership Manager Sonia Moss, who congratulated Yvonne, Lois and Chris for being an integral part of their local health district.
-
New meds safety app
Monday | Dec 10 2018A NEW smart device app has been created to assist people with limited vision to increase their knowledge of drugs they are taking.
-
New APC exam practice papers
Monday | Dec 10 2018THE Australian Pharmacy Council (APC) has released two new additional practice papers for candidates planning to sit the APC Intern Written Examination or the Competency Assessment of Overseas Pharmacist examination.
-
Deferasirox not a-flag
Monday | Dec 10 2018THE Health Department has highlighted to prescribers that the deferasirox (Jadenau/Exjade) 'N'mg dispersible tablet and 'N'mg film coated tablet are equivalent for the purposes of substitution, but are not a-flagged to permit pharmacist substitution in the dispensary.
-
BP anti-inflammatory treatment
Monday | Dec 10 2018LA TROBE University and the Baker Heart and Diabetes Institute are leading a major new study into the causes of high blood pressure (BP) and have found a possible link with chronic inflammation.
-
Cash-flow support
Monday | Dec 10 2018THE Federal Government has detailed measures in the 2018-19 Budget which aim to ease the burden on pharmacies stocking high-cost drugs.
-
API “tough market”
Monday | Dec 10 2018AUSTRALIAN Pharmaceutical Industries says it expects the retail market to continue to remain tough, with consumers cautious in their spending habits.
-
$30m DoseMe deal
Monday | Dec 10 2018BRISBANE-BASED precision medication dosing provider DoseMe is set to be acquired by US-listed firm Tabula Rasa Healthcare, in a deal reportedly worth up to US$30 million.
